i-sense continues diagnostic development during COVID-19 lockdown
In mid-March, when the UK went into lockdown, a small group of researchers were given special access to i-sense labs in London, under modified safety measures. They were tasked with the important job of working collaboratively to develop point-of-care diagnostic tests...
Nanomaterial solution with the potential to fight aggressive cancer
LCN Professor Julian Jones has led research into finding a nanomaterial solution which has the potential to fight aggressive breast cancer. The research highlights how Zinc-loaded particles might have the potential to fight triple-negative breast cancer, an aggressive...
The LCN collaborates with the University of Toronto to understand transport machinery in cells
The London Centre for Nanotechnology and Toronto researchers are collaborating to inform better therapies for illnesses such as motor neurone disease and cancer and to identify anti-viral therapies In 2017, Professor Bart Hoogenboom (London Centre for Nanotechnology,...